Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles
Positive volume growth was observed in key therapies such as respiratory (13.2% yoy), anti-neoplastics (12.1% yoy) and cardiac (4.8% yoy) during September 2025
The collaboration combines the extensive CMC expertise of Sai Life Sciences in API development, Agility Life Sciences in formulation development, and Centrix Pharma Solutions in drug product development and clinical manufacturing
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
New study presents a human-relevant stress model for assessing potential therapeutics
Stephan brings more than 20 years of leadership experience in the pharmaceutical industry
These products strengthen poultry immunity, improve productivity, and support sustainable farming practices~
Max and Luna personify HRV Pharma’s core values of trust, loyalty, and authentic partnership
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
Subscribe To Our Newsletter & Stay Updated
